cibenzolineBeta blockersJapanese Hypertrophic Cardiomyopathy Registry StudySeptal reduction therapieshypertrophic cardiomyopathyHOCM
…ere prescribed to 90% of patients with HOCM, while 51% received cibenzoline. Septal reduction therapies were performed in 22% of patients w…